Document ID: chunk:federal_register_of_legislation:F2022L00005:reg:7
Version: federal_register_of_legislation:F2022L00005
Segment Type: reg
Provision Reference: reg 7
Character Range: 1627–3374

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about goitre and death from goitre.
Meaning of goitre
(2)          For the purposes of this Statement of Principles, goitre:
(a)          means an enlarged thyroid gland that has persisted for at least 4 weeks; and
(b)          includes:
                (i)             a diffuse enlargement; and
                (ii)          enlargement due to a solitary thyroid nodule (thyroid adenoma) or multiple nodules of the thyroid gland; and
(c)          excludes:
                (i)             congenital goitre;
                (ii)          dyshormogenetic goitre;
                (iii)        Graves disease;
                (iv)         Hashimoto thyroiditis;
                (v)           haemorrhage or infarction of the thyroid gland; and
                (vi)        primary or secondary malignancy, including malignant neoplasm of the thyroid gland.
             Note 1: Goitre may be identified by a palpable or visible swelling in the front of the neck, or by imaging assessment.
             Note 2: The diagnosis is not dependent on thyroid hormone levels.  Thyroid function may be normal (nontoxic goitre), overactive (toxic goitre), or underactive (hypothyroid goitre).
            Note 3: Toxic goitre may present as a thyrotoxic crisis.
            Note 4: thyrotoxic crisis is defined in the Schedule 1 - Dictionary.
Death from goitre
(3)          For the purposes of this Statement of Principles, goitre, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's goitre.
Note: terminal event is defined in the Schedule 1 - Dictionary.